AxioMed Spine

What AxioMed Spine does

AxioMed Spine is a privately held medical device company developing viscoelastic spinal disc replacement technologies under its Freedom Disc Platform. Founded in 2001 in Cleveland, Ohio by Cleveland Clinic surgeons and AcroFlex engineers (including individuals who worked with Dr. Arthur Steffee), the company was acquired by KIC Ventures in 2014 and is now a wholly-owned subsidiary operating as AxioMed LLC from Fort Lauderdale, Florida, with manufacturing in a validated cleanroom in Massachusetts. Its core technology is a single-piece silicone polycarbonate urethane elastomeric core permanently bonded between titanium endplates, engineered to replicate the flexibility, six degrees-of-freedom motion, and shock absorption of a healthy human disc and to produce 70% less wear with biologically safer particles than ball-and-socket designs.

The Freedom Disc Platform comprises the Freedom Lumbar Disc (the only viscoelastic lumbar disc to complete a U.S. FDA IDE clinical study, with 300 patients randomized against ProDisc in a 2015 pivotal trial and investigational in the US), the Freedom Cervical Disc (8+ years of international clinical experience across Europe, Australia, and the Caribbean, not available in the US), the Freedom Lateral Lumbar Disc (in development), and the AxioMEDx Freedom DiscSx (a 2023 spinout developing a sensor-enabled smart total disc replacement). Over 800 discs have been implanted worldwide with zero device failures reported, and clinical follow-up extends to 13+ years in some patients.

AxioMed's business model is currently pre-revenue from US commercial sales due to investigational device status, with planned FDA approval filing in 2026. Its go-to-market targets spine surgeons and ambulatory surgery centers (ASCs), positioning motion-preserving disc replacement as an upstream alternative to the more than 500,000 lumbar fusion procedures performed annually in the US, and as a channel shift from hospital-based reconstruction to outpatient settings. The company has raised more than $95 million across multiple funding events from 2003 through 2022 and is currently raising a Series C financing round.

Name

AxioMed Spine

Legal name

AxioMed LLC

Website

https://axiomed.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

AxioMed Spine is a privately held medical device company developing viscoelastic spinal disc replacement technologies (Freedom Disc Platform) for patients with degenerative disc disease, targeting spine surgeons and ambulatory surgery centers as a wholly-owned KIC Ventures subsidiary.

Ownership category

akta.pro rank

Product category

Spinal Disc Replacement Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

Keywords

• Spinal disc replacement
• Viscoelastic implants
• Motion preservation devices
• Orthopedic spine surgery
• Medical device manufacturing

Headquarters

HQ city

Malden

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Motion-Preserving Disc Replacement: AxioMed is currently pre-revenue as the Freedom Lumbar Disc is an investigational device limited by US law to investigational use. The company is preparing for FDA approval in 2026 and international commercialization. Revenue will be generated through medical device sales to healthcare providers and ASCs upon regulatory approval.
2. Series C Financing: Currently raising a Series C financing round offering investors opportunity to participate through self-directed IRAs (SDIRAs). More than $95 million invested to date. Investment enables continued clinical trials, FDA approval process, and commercialization preparations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

AxioMed develops and manufactures viscoelastic spinal disc replacement implants under the Freedom Disc Platform. The company's core products are the Freedom Lumbar Disc (FLD), the only viscoelastic lumbar disc replacement to complete a U.S. FDA IDE clinical study, and the Freedom Cervical Disc (FCD), sold internationally. Devices consist of a single-piece silicone polycarbonate urethane elastomeric core permanently bonded between titanium endplates, designed to replicate the flexibility and shock absorption of a healthy human disc for patients with degenerative disc disease.

Product overview

AxioMed develops the Freedom Disc Platform, a family of viscoelastic spinal disc replacement technologies engineered from a single-piece silicone polycarbonate urethane elastomeric core designed to replicate the flexibility and shock absorption of a healthy human disc. The platform includes the Freedom Lumbar Disc (FDA IDE completed, investigational in US), Freedom Cervical Disc (available internationally), and Freedom Lateral Lumbar Disc (in development). A spinout company AxioMEDx was founded in 2023 to develop the smart sensor-enabled Freedom DiscSx. All products share a common viscoelastic core technology that provides six degrees-of-freedom motion, MRI compatibility, and multiple size and lordosis options.

Differentiator

Problem solved

Functional benefit

Brands

• Freedom Disc Platform: Viscoelastic spinal disc replacement technology platform featuring a single-piece silicone polycarbonate urethane elastomeric core designed to replicate the flexibility and shock absorption of a healthy human disc.
• Freedom Cervical Disc
• Freedom Lumbar Disc
• Freedom Lateral Lumbar Disc
• AxioMEDx Smart Disc

Products and services

• Freedom Lumbar Disc (FLD) Viscoelastic lumbar disc replacement featuring a single-piece silicone polycarbonate urethane elastomeric core permanently bonded between titanium endplates that allows compression under load and multi-plane motion. The only viscoelastic lumbar disc replacement to complete a U.S. FDA IDE clinical study, with zero device failures across nearly 1,000 implants in 10-year clinical follow-up. Indicated for skeletally mature patients with single-level symptomatic degenerative disc disease from L3-S1. Investigational device in the U.S., pending 2026 FDA approval.
• Freedom Cervical Disc (FCD) Viscoelastic cervical disc replacement with 8+ years of international clinical experience in Europe, Australia, and the Caribbean, designed to restore natural cervical spine motion in patients with degenerative disc disease. Not available in the United States.
• Freedom Disc Platform Family brand for AxioMed's viscoelastic spinal disc replacement technologies, comprising a single-piece silicone polycarbonate urethane elastomeric core designed to replicate the flexibility and shock absorption of a healthy human disc with six degrees-of-freedom motion, MRI compatibility, and multiple size and lordosis options.

Quantifiable outcome

• 70% less wear and biologically safer particles compared to traditional ball-and-socket designs
• +5 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• NANISXcoreStrategic or Co-development Partner · 11 March 2026Partnership with NANISX as part of KIC Ventures' LESS (Less Exposure Spine Surgery) philosophy and REP principles. NANISX collaboration with AxioMed for viscoelastic disc technology designed to restore natural spinal motion. The NANISX platform represents treatment philosophy focused on less invasive approaches aligned with motion-preserving technology.
• AxioMEDxcoreStrategic or Co-development Partner · 1 January 2023AxioMEDx is a next-generation spinout of AxioMed founded in 2023 to lead development of smart sensor technologies for spine and orthopedic medical devices. Combining advanced sensor software with AxioMed's proven viscoelastic Freedom Disc platform to create the Freedom DiscSx—a first-of-its-kind smart total disc replacement with integrated sensing capabilities.
• Cleveland Clinic (Historical)minorStrategic or Co-development PartnerHistorical founding relationship—in 2001, surgeons at Cleveland Clinic and AcroFlex engineers, including individuals who worked with Dr. Arthur Steffee on the AcroFlex technology, founded AxioMed Corporation. This established the company's origins in spinal disc innovation.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Spinal Elements: Spine technology company focused on procedural innovation and motion-preservation-adjacent technologies. Comparable as a smaller-scale spine innovator with similar ASC/outpatient ambitions and surgeon-focused GTM.
• SeaSpine: U.S. spine-focused company developing procedural solutions and cervical/lumbar interbody devices. Comparable as a mid-scale spine specialist competing for surgeon adoption and ASC contracts adjacent to motion-preservation.
• Alphatec Spine: Pure-play spine company focused on lateral and minimally invasive approaches including motion-preservation-adjacent procedures. Comparable as a U.S. spine specialist pursuing ASC and outpatient expansion, similar to AxioMed's go-to-market motion.

Direct peers

• Orthofix Medical: Spine and orthopedic device company offering the M6-C artificial cervical disc and other motion-preservation technologies. Direct competitor in viscoelastic-style cervical disc replacement, the segment where AxioMed's Freedom Cervical Disc has international experience.
• Globus Medical: Acquired NuVasive and its Simplify Disc cervical artificial disc, and offers a broad motion-preservation portfolio. Competes with AxioMed across lumbar and cervical disc arthroplasty in U.S. spine centers and ASCs.
• Aesculap (B. Braun): Markets the activL lumbar artificial disc, an FDA-approved motion-preserving alternative to spinal fusion. Directly competes with AxioMed's Freedom Lumbar Disc in the same patient population and surgical setting.
• Centinel Spine: Spine-focused private company that markets the ProDisc-L FDA-approved lumbar total disc replacement and ProDisc-C cervical disc. Most direct comparator to AxioMed's Freedom platform given head-to-head use of ProDisc as the control in AxioMed's IDE trial.

Broad incumbents

• Medtronic: Largest spine incumbent with the Prestige LP cervical disc and broad enabling technology for ASC-based spine surgery. Provides scale, surgeon relationships, and capital that any motion-preservation entrant must compete against.
• Zimmer Biomet: Diversified orthopedic and spine player with cervical disc and motion-preservation assets. Relevant comparator for procedural mix, ASC strategy, and surgeon training scale relative to AxioMed's pre-commercial footprint.
• Stryker: Major spine and orthopedic medtech with cervical disc and ASC-focused surgical offerings. Competes indirectly with AxioMed by leveraging broad hospital contracts, Mako-enabled spine workflows, and integrated capital/implants bundles.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@axiomed911
• LinkedInlinkedin.com/company/axiomed

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds11 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AxioMed Spine